Cargando…
Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy
Diabetic peripheral neuropathy (DPN) remains one of the most common and serious complications of diabetes. Currently, pharmacological agents are limited to treating the pain associated with DPN, and do not address the underlying pathological mechanisms driving nerve damage, thus leaving a significan...
Autores principales: | Cox, April Ann, Sagot, Yves, Hedou, Gael, Grek, Christina, Wilkes, Travis, Vinik, Aaron I., Ghatnekar, Gautam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411416/ https://www.ncbi.nlm.nih.gov/pubmed/28512447 http://dx.doi.org/10.3389/fendo.2017.00089 |
Ejemplares similares
-
Evaluation of a connexin-based peptide for the treatment of age-related macular degeneration
por: Obert, Elisabeth, et al.
Publicado: (2022) -
Grand Challenges in Diabetes
por: Vinik, Aaron
Publicado: (2012) -
The Conductor of the Autonomic Orchestra
por: Vinik, Aaron I.
Publicado: (2012) -
Kisspeptin-neuron control of LH pulsatility and ovulation
por: Stevenson, Harvey, et al.
Publicado: (2022) -
Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy
por: Yang, Cunqing, et al.
Publicado: (2023)